Fincantieri SpA (FCT IM) 9M 2026 (EUR): EBITDA 511mln, Revenue 6.61bln
Newsquawk Staff ·
- EBITDA margin 7.7%.
- Orders 9.7bln.
What it means
Fincantieri's nine-month print lands in the format the market has come to trade it on: less the revenue line, more the margin trajectory and the order intake. The group has spent recent years executing a margin rebuild from low-single-digit levels toward its stated targets, so a 7.7% EBITDA margin reads against that trajectory rather than against a consensus the headline does not carry. Orders of 9.7bln matter more than the P&L for a shipbuilder whose equity case rests on backlog conversion; the book-to-bill implied here is well above one, and in past reporting periods strong intake has been the driver of the stock more than quarterly profitability. The peer set is the European defense and naval complex, where rearmament-driven naval demand has re-rated contractors and where Fincantieri's cruise, naval, and offshore mix gives it exposure to both commercial and government cycles, two legs that behave differently on any macro wobble. The distinction worth drawing is between cruise deliveries, which are price-fixed legacy contracts sensitive to cost inflation, and naval work, which carries better economics and geopolitical tailwinds. Follow-ons are the margin guidance language on the call, any update on defense consolidation or partnerships, and the year-end backlog figure, which is where the order momentum either confirms or stalls.
- Zealand Pharma (ZEAL DC) says Boehringer Ingelheim intends to conduct a regulatory submission for survodutide in 2027. Favourable cardiovascular safety supports the submission.
- DiaSorin (DIA IM) 9M 2026 (EUR): Revenue 910mln; Adj. EBITDA 297mln; Adj. EBIT 228mln; Adj. net income 159mln; Q3 revenue +8% at constant FX; 2026 guidance confirmed, including Adj. EBITDA margin 32-33%
- EUROPEAN OPEN: NVDA falls amid further CEO allegations; Hon Hai Q3 profit tops expectations; SIE GY Q4 revenue beat, confirms SHL GY distribution; RR/ LN announces GBP 1.5bln buyback; MRK GY raises FY26 revenue & EBITDA view; HLAG GY lifts EBITDA guidance
- Newsquawk Daily European Equity Opening News - 12th November 2026
- Royal Unibrew (RBREW DC) Q3 2026 (DKK): Revenue 4.35bln (exp. 4.3bln), EBIT 820mln (exp. 815mln). FY Guidance narrowed
Related headlines
- Wienerberger (WIE AV) makes interim CEO Hanke permanent, with immediate effect22 hours ago
- SNAMS (SRG IM) board is reportedly considering the sale of its biomethane unit, according to source reports1 day ago
- De' Longhi (DLG IM) Q3 2026 (EUR): Revenue 944mln (exp. 924mln), adj. EBITDA 172mln (exp. 163mln). FY Guidance: adj. EBITDA 685-705mln (exp. 683mln)1 day ago
- EU Commission is strengthening consumer protection laws, making them fit for the digital age1 day ago
- Hapag Lloyd (HLAG GY) further raises its earnings outlook for the current financial year; sees FY EBITDA USD 4.6-5bln (prev. guided 3.9-5bln), and sees EBIT 2-2.4bln (prev. guided 1.25-1.75bln)1 day ago
- EUROPEAN OPEN: TIT IM beats in Q3; ABN NA raises FY26 NII guidance; ENR GY Q4 net income and revenue beat; RWE GY sees net income near upper end of range; EOAN GY reaffirms EBITDA guidance; ALC SW narrows FY26 outlook1 day ago
- European Pre-Market Summary 11th November 2026: Earnings continue to file in, broader equity focus on the NQ rebound1 day ago
- Additional European Equity News - 11th November 20261 day ago
- Newsquawk Daily European Equity Opening News - 11th November 20261 day ago
- Telecom Italia (TIT IM) Q3 2026 (EUR): EBITDA 1.05bln (exp. 1.04bln), Revenue 3.61bln (exp. 3.60bln); affirms outlook1 day ago
- Canadian PM Carney says Stellantis (STLAM IM) is not respecting its obligations to Canada1 day ago
- French Armed Forces reportedly veto the proposed acquisition of KNDS supplier Dixi Microtechniques by CSG, Les Echos reports citing sources1 day ago
- German government to purchase 50% of KNDS for EUR 6.6bln, AFP reports citing sources2 days ago
- Banca Generali (BGN IM) upgrades FY26 AUM inflow target2 days ago
- Lundbeck (LUNDB DC) Q3 2026 (DKK): Revenue 6.6bln (exp. 6.33bln), adj. EBITDA 2.26bln (exp. 1.96bln). Raises FY guidance.2 days ago